This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
TWYNSTA
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TWYNSTA in Canada?
A shortage of TWYNSTA 80MG 5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 2, 2026), but it has not started yet.
Why is TWYNSTA not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TWYNSTA be available again?
The manufacturer's estimated resolution date is December 14, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02371049
Strength
80MG 5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TELMISARTAN AMLODIPINE
Tier
Unrated
Last Updated
2026-11-02
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
TWYNSTA has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
20MCG · DIN 02247686
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
20MG · DIN 02415666
40MG · DIN 02415682
30MG · DIN 02415674
DIN 02459752
DIN 02459760
DIN 02441888